← Back

Real-Time Dynamics of Patient Molecular Biology

The ability to study the real-time dynamics of molecular pathways in living humans remains extremely limited in time-resolution (frequency and duration) and scalability (beyond lab testing). Continuous, minimally invasive technologies are needed to improve our understanding of human physiology, accurately diagnose patients, and assess the impact of clinical interventions. Molecular engineering, particularly protein engineering, and integrated circuit design can be combined to develop new, miniaturized devices.

R&D Gaps (1)

Clinical trial designs are often inefficient, resulting in high costs, lengthy timelines, and suboptimal patient outcomes. Innovative trial designs and decision-support tools are required to streamline the clinical evaluation process and accelerate therapeutic development.